Bayer to invest more in health, nutrition sector

Acknowledging China's foreign business environment and opening-up policies for multinational corporations, German life sciences company Bayer is committed to investing in essential health and nutrition solutions in the country in order to serve a broad base of patients, consumers and growers, said its top executive.

"I sincerely appreciate the Chinese government for its recent initiatives aimed at opening up the cell and gene therapy area to foreign investment. The pilot program, introduced by the Chinese government in 2024, is a significant step forward, allowing foreign businesses to participate in the development and commercialization of these groundbreaking therapies," said Bill Anderson, CEO of Bayer.

Anderson made the remarks after he, together with around 40 other representatives of the international business community, met with China's top leadership in Beijing on March 28.